跳至主要内容
临床试验/DRKS00018112
DRKS00018112进行中(未招募)不适用

Methodological study for the development of a software application for speech analysis in patients with Alzheimer’s disease ranging from mild cognitive impairment to moderate severity - DeSoApp-AD-study

Boehringer Ingelheim International GmbH0 个研究点目标入组 199 人开始时间: 2019年9月24日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
199

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
55 Years 至 one(—)
性别
All

入选标准

  • Diagnosis of Alzheimer’s disease ranging from mild cognitive impairment to moderate severity according to NIA/AA criteria (patients) or cognitive test performance in CERAD battery within normal limits (cognitively healthy controls of comparable age)
  • 2. Age >55 years
  • 3. Adequate vision, hearing, comprehension of German language and speech formation abilities to allow testing

排除标准

  • 1. Exclusion of any other medical condition interfering with cognitive functioning, including clinical sings of depression
  • 2. Exclusion of any medical condition which prohibits the use of a tablet-based application
  • 3. Exclusion of any psychotropic medication that interferes with cognitive functioning/performance

研究者

相似试验

Methodological study for the development of a... | 临床试验